Developed by:
Pfizer Inc. (USA)

Objective:
To assess satisfaction with and preference for chemotherapy treatment, and for biological therapy in either pill or IV form

Copyright:
CTSQ © 2007 Pfizer Inc. All rights reserved.

Reference publications:
Abetz L, Coombs JH, Keininger DL, Earle CC, Wade C, Bury-Maynard D,Copley-Merriman K, Hsu MA. Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health. 2005 Nov-Dec;8 Suppl 1:S41-53.

Trask PC, Tellefsen C, Espindle D, Getter C, & Hsu M-A. Psychometric validation of the Cancer Therapy Satisfaction Questionnaire (CTSQ). Value in Health. 2008 Jul-Aug;11(4):669-79. Epub 2008 Jan 8


Conditions of use:

1. User Agreement:

Existing translations: user is required to complete and sign a User Agreement with Pfizer Inc. in which specific conditions required by Pfizer Inc. are detailed.

New translation(s): in addition to the User Agreement, user is required to complete and sign a Translation Agreement with Pfizer Inc.


2. Access Fees:

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 €* per language version

- In commercial studies (3) involving "for-profit" organizations: 700 €* per study + 250 €* per language version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:

Original US English version available for review purpose only. Please click here to access.


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have two original copies of the User Agreement and/or Translation Agreement completed, dated and signed and return them both to MAPI Research Trust by post. As soon as we receive them, we will process your request.

More information on CTSQ on PROQOLID

[ BACK ]